Measles Is at a 35-Year High in the US. Why It Spreads So Fast

Key takeaways

• 2,318+ cases by late July 2026, past 2025's full-year total. Worst US measles year since 1991.
• 93% of patients were unvaccinated or of unknown vaccination status. 69% were under 19.
• Measles has an R0 of 12–18 — the most contagious known human virus. Influenza is about 2–3.
• Stopping transmission needs about 95% two-dose coverage, a higher bar than almost any other disease.
• Elimination status — no continuous transmission for 12 months — was gained in 2000 and is under formal review this autumn.

What the 2026 numbers actually say

The headline figure is the case count, but the composition of that count is where the information is.

	2025 (full year)	2026 (to late July)
Confirmed cases	2,289	2,318
Hospitalisation rate	11%	7%
Deaths	3 (including two children)	0
Unvaccinated or unknown status	—	93%

Two things stand out.

First, 93% of the people infected were unvaccinated or had unknown vaccination status. This is the single most informative number in the dataset. It is not evidence that the vaccine is failing; it is close to the opposite. In a country with high but falling coverage, an outbreak that concentrates this sharply in the unvaccinated is what a well-functioning vaccine looks like under strain.

Second, 69% of cases were in people under 19. Measles is not selecting for children because children are biologically special here — it is finding them because that is where the susceptible pool is. Adults born before 1957 generally have immunity from infection; those vaccinated in childhood mostly still have it. The unimmunised cohort is young.

The outbreak is not one event. Case clusters have run in Utah (514), Virginia (177), Pennsylvania (139) and Arizona (119), with newer clusters appearing in Delaware and Wyoming. That geographic scatter is the signature of a virus that has stopped being an imported curiosity and started circulating.

The one piece of genuinely good news in the table: hospitalisations ran at 7% in 2026 against 11% in 2025, and no deaths had been recorded at the time of reporting, against three the previous year. Case-fatality in a country with intensive care available is low — but "low" here still means one to three deaths per thousand cases, and the count is still climbing.

Why measles specifically

Every vaccine-preventable disease benefits from high coverage. Measles is the one that punishes falling coverage first, and it does so for a reason that can be written down as a number.

The basic reproduction number, R0, is the average number of people one infected person infects in a population with no immunity. For seasonal influenza it is roughly 2 to 3. For the original SARS-CoV-2 strain, estimates clustered around 2 to 3.5. For measles it is 12 to 18 — the highest reliably measured for any human virus.

Three properties produce that figure:

• It is genuinely airborne. Not droplet-borne — measles travels on fine aerosols that stay suspended. Infectious virus can persist in the air of a room for up to two hours after the infected person has left it. Transmission has been documented between people who were never in the same room at the same time.
• The attack rate is extraordinary. Around 90% of susceptible people exposed to measles catch it. Exposure is very close to infection.
• People are contagious before they know they are ill. Infectiousness begins about four days before the rash appears, during a phase that looks like fever, cough, runny nose and conjunctivitis — indistinguishable from an ordinary respiratory infection. By the time measles is recognisable, the person has been spreading it for the better part of a week.

The 95% threshold, and why it is unforgiving

The proportion of a population that must be immune to stop sustained transmission is approximately 1 − 1/R0. The arithmetic is what makes measles unusual.

Disease	Approx. R0	Immunity needed
Influenza (seasonal)	2–3	~50–65%
COVID-19 (ancestral)	2–3.5	~50–70%
Polio	5–7	~80–86%
Measles	12–18	~92–95%

At an R0 of 18, you need roughly 94.4% of the community immune. Public health targets round this to 95% two-dose coverage, and that number is the whole story of the current outbreak.

It means measles has almost no tolerance for slippage. A community at 90% coverage — which sounds high, and which would comfortably suppress most diseases — is below the measles threshold and will sustain an outbreak once the virus arrives. There is no partial credit. This is also why measles is used as an early-warning indicator for the health of an entire immunisation programme: it breaks through first, so a measles outbreak usually signals that coverage for several other diseases has quietly fallen too.

It also means the relevant coverage figure is local, not national. A national average of 93% can conceal school districts at 99% and districts at 75%. The virus does not encounter the average; it encounters a particular classroom.

What elimination status means, and what losing it does not mean

"Elimination" has a technical definition that is narrower than the everyday word: the absence of continuous measles transmission in a defined geographic area for more than 12 months. The US achieved it in 2000. An expert panel reviews the evidence and makes the determination.

Losing it would mean that at least one chain of transmission has run unbroken for over a year — that measles is circulating domestically again, rather than only being imported by travellers and then stamped out.

It is worth being precise about what that does and does not signify.

It does not mean measles is now widespread, that vaccination has failed, or that the risk to a vaccinated person has meaningfully changed. Two doses of MMR remain about 97% effective, and that protection is generally lifelong.

It does mean a 26-year public health achievement has lapsed, that the virus now has a domestic reservoir to spread from rather than needing reintroduction each time, and that future outbreaks start closer to home and are harder to contain. It is a status that took decades of sustained coverage to earn and can be lost in two bad years.

The complication most people have never heard of

The standard list of measles complications is well known enough: about one in 20 children with measles develops pneumonia — the most common cause of measles death in the young; about one in 1,000 develops encephalitis, which can leave permanent deafness or intellectual disability; one to three per 1,000 die even with modern care. Rarer and worse is subacute sclerosing panencephalitis (SSPE), a progressive, invariably fatal brain disease that appears seven to ten years after apparent recovery. It is rare overall but substantially more likely in children infected as infants.

The one that changes how you should think about the disease is immune amnesia.

Measles infects and destroys memory immune cells. In doing so it erases a portion of the immunity a person had already built up — from previous infections and from previous vaccinations. Research published in Science in 2019 found measles wiped out somewhere between 11% and 73% of a child's existing antibody repertoire, effectively resetting parts of their immune memory to an earlier state.

The consequence is that measles is not a single illness with a recovery date. For two to three years afterwards, a child who has had measles is measurably more susceptible to other infections they were previously protected against. Historical epidemiology bears this out: measles vaccination campaigns have been followed by drops in child mortality far larger than the number of measles deaths alone could explain.

Immune amnesia is also why the "let them catch it naturally, it builds immunity" argument is not just wrong but inverted. Natural measles infection produces robust immunity to measles while destroying immunity to a good deal else. The vaccine produces the former without the latter — which is the general shape of why vaccines work at all: the same immunological training, minus the disease and its collateral damage.

The honest uncertainties

Several things in this story are genuinely unsettled, and it is worth separating them from the things that are not.

Settled: measles is airborne and extraordinarily contagious; MMR is about 97% effective after two doses; the vaccine does not cause autism — the 1998 paper claiming a link was retracted for fraud, its author struck off the medical register, and the question has since been examined in studies covering millions of children across multiple countries without finding an association.

Not settled: where the 2026 count finishes; whether the elimination determination goes against the US this autumn or is deferred; how much of the coverage decline is refusal versus access, disruption and missed routine appointments, which have different policy answers; and the precise contribution of any single cluster to the national trajectory, since case attribution lags reporting.

The number to watch is not the case count. It is local two-dose coverage — because that is the variable that decides whether the next importation goes nowhere or becomes next year's outbreak.

Sources: CIDRAP — CDC: ever-expanding US measles outbreak tops last year's total; NBC News — US measles cases hit 35-year record; CNN — US measles cases reach 35-year high. Case figures are as of late July 2026 and continue to be updated weekly by the CDC.